Related Articles
- Diabetes care: whose responsibility? // British Medical Journal (Clinical Research Edition);6/1/1985, Vol. 290 Issue 6482, p1629
Focuses on diabetes care in Great Britain. Structure of diabetes care in medical facilities; Common therapies and drugs used in general practice; Evaluation of the efficacy of diabetes intervention.
- Prevention of Type 1 Diabetes Mellitus. // Diabetes Care;Jan2002 Supplement, Vol. 25, pS131
Presents a position statement from the American Diabetes Association, on the prevention of type 1 diabetes mellitus in the United States. Use of intervention therapy to prevent β-cell destruction in diabetes patients; General information on diabetes; Screening of diabetes patients.
- GPs struggling with diabetes BP targets. Pedder, Cato // Pulse;6/7/2004, Vol. 64 Issue 23, p9
Focuses on research on the efforts of general practitioners in treating blood pressure and cardiovascular diseases presented at the American Diabetes Association conference. Competency of general practitioners on the use of hypertension drugs; Attainment of blood pressure targets in patients...
- Practices could lose thousands over 'unachieveable' diabetes targets. Gough, Rob // Pulse;3/24/2003, Vol. 63 Issue 12, p10
Reports on the results of Great Britain Prospective Diabetes Study, showing challenges facing general practitioners to achieve key diabetes targets in the contract's quality and outcomes framework. Failure of intensive drug therapy to lower HbA levels in patients with type 2 diabetes; Effect of...
- Understanding Type II diabetes. Trenciansky, Stephanie // Alive: Canada's Natural Health & Wellness Magazine;Nov2002, Issue 241, p60
Offers information on Type II or non-insulin dependent diabetes. Inclusion of the difference between Type I diabetes; Symptoms; General medical consensus on treatment of Type II diabetes that lifestyle management is at the forefront of therapy options; Dietary recommendations; Importance of...
- Complex choices in diabetes care. // GP: General Practitioner;10/17/2012, p14
The article reports that treatment of diabetes has become difficult for general practitioners (GPs) as GPs should choose diabetes care from the widening options for diabetes treatment. It mentions that until 2002 only four main therapies available were: insulin, metformin, sulfonylureas and...
- DCCT/EDIC 30 years later: Positive effects of intensive therapy confirmed in type 1 diabetes. Adams, Stacey L.; Costa, Samantha; Foster, Melissa // Endocrine Today;Jul2013, Vol. 12 Issue 7, p14
The article discusses the highlights of the American Diabetes Association (ADA) Scientific Sessions held on June 21-25, 2013 in Chicago, Illinois, including the significance of intensive insulin therapy for patients with type one diabetes discussed by David M. Nathan, director of the...
- Easing the burden of diabetes care. Betty, Bryan // New Zealand Doctor;7/27/2011, p44
The article discusses issues that should be addressed by general practitioners (GP) in providing diabetes care based on the new guidelines, "Guidance on the Management of Type 2 Diabetes." The guidelines include a risk chart that indicate the risk factors to identify whether a patient is...
- Treatment of Diabetic Neuropathy with Pentoxifylline: Case Report. Kalmansohn, Robert B.; Kalmansohn, Richard W.; Markham, Charles H.; Schiff, David L. // Angiology;Apr1988, Vol. 39 Issue 4, p371
Diabetic neuropathy includes a heterogenous group of neuropathic syndromes associated with diabetes mellitus. One form of diabetic neuropathy is distal symmetric polyneuropathy, which is characterized at a stage by intractable pain. This pain is generally refractory to present modalities of...
- CPD Challenge. // Africa Health;Nov2013, Vol. 36 Issue 1, p45
A quiz concerning diabetes, malaria and antimicrobial therapy is presented.